Form 8-K - Current report:
SEC Accession No. 0001193125-25-208187
Filing Date
2025-09-19
Accepted
2025-09-19 07:41:30
Documents
10
Period of Report
2025-09-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K prld-20250918.htm   iXBRL 8-K 44550
  Complete submission text file 0001193125-25-208187.txt   181827

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20250918.xsd EX-101.SCH 50256
12 EXTRACTED XBRL INSTANCE DOCUMENT prld-20250918_htm.xml XML 4721
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 251324937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)